Redbarn Bets Functional Treats Can Win Shelf Space Treats Already Lost200 Free Gifts, Zero Shelf Strategy: What Barkwow's DTC Launch Says About the Personalized Pet Gift Category$1.4B Mars Spend Puts Independent Pet Retail in the SqueezePets at Home's Poppy Appeal Hit £1.6M Since 2018. The Charity-SKU Model Most Indies Can't Run.The Donation Box Fourteen Petland Stores Put Up in October Solves a Problem Most Retailers Don't SeeKnit Harnesses Challenge the Webbing-Foam Stack Every Store StocksPaleo Ridge Gives Independents a Margin Choice This Black FridayRay and Naz opened a Pet Supplies Plus in San Antonio after their dog got sprayed by a skunkRedbarn Bets Functional Treats Can Win Shelf Space Treats Already Lost200 Free Gifts, Zero Shelf Strategy: What Barkwow's DTC Launch Says About the Personalized Pet Gift Category$1.4B Mars Spend Puts Independent Pet Retail in the SqueezePets at Home's Poppy Appeal Hit £1.6M Since 2018. The Charity-SKU Model Most Indies Can't Run.The Donation Box Fourteen Petland Stores Put Up in October Solves a Problem Most Retailers Don't SeeKnit Harnesses Challenge the Webbing-Foam Stack Every Store StocksPaleo Ridge Gives Independents a Margin Choice This Black FridayRay and Naz opened a Pet Supplies Plus in San Antonio after their dog got sprayed by a skunk
Deals & M&ABy The PetRetailNews Desk3 min readNovember 4, 2026
Cultivated Meat Startup Meatly Moved Into Imperial College Manufacturing Facility
The company raised £10.4 million in May and says it will create Europe's largest cultivated meat facility at the North Acton site.
Meatly, the cultivated meat company that became the first to sell lab-grown pet food in Europe in 2025, moved into Imperial College London's pilot manufacturing facility in North Acton. The company said it will begin its first commercial-scale production runs in 2027.
The facility decision and what it bought
The move puts Meatly at Grapht Works, Imperial College's dedicated site for deep tech companies transitioning from research to scalable manufacturing. The company is using capital from its £10.4 million Series A round, announced in May, to fund the relocation and buildout.
Meatly chief executive Owen Ensor said the company will create Europe's largest cultivated meat facility at the site. Imperial built Grapht Works specifically for companies moving from R&D into production, so Meatly gets manufacturing infrastructure without building its own plant, and Imperial gets a tenant proving out the model.
Meatly received UK regulatory authorization in 2024 and launched the world's first cultivated pet food product in 2025. The company has developed its own bioreactors and culture medium, the two pieces of infrastructure that typically determine whether cultivated meat economics work at scale.
The timeline and what it means for shelf decisions
The 2027 production target puts first meaningful volume at least two years out, and volume is not the same as distribution. A buyer deciding shelf space today faces no immediate cultivated meat decision. The category remains a watch item, not an assortment decision.
What the announcement does not include: pricing, retail partnerships, or a go-to-market strategy. Meatly has regulatory clearance and a product that shipped in limited release, but moving to pilot manufacturing does not answer whether the economics hold at commercial scale or whether independents will stock it when it does.
The Series A capital appears focused on proving the manufacturing model rather than building a sales channel. That is the correct sequencing, distribution deals before you can produce at cost are theater, but it pushes any retail conversation further out.
Our read: the infrastructure move matters more than the timeline
The Grapht Works partnership is the actual news. Cultivated meat companies typically hit a wall between lab-scale production and commercial manufacturing. The bioreactor that works for samples does not scale linearly, and building your own facility before proving unit economics kills most startups in this space.
Meatly is renting the infrastructure to prove the model, which means they are spending capital on production runs rather than construction. If the economics work, they have a facility that can demonstrate it to retail buyers and investors. If they don't, the company has not sunk Series A money into a plant it cannot use.
The 2027 target is aspirational until it is not. We have seen enough cultivated protein timelines slip to treat any date more than 18 months out as a planning assumption rather than a launch window. We are watching whether Meatly announces a second funding round before 2027, which would signal the manufacturing costs are higher than the Series A assumed, or whether they go quiet and hit the timeline, which would mean the model worked.
What this means if you stock premium or novel protein
If you already carry insect-based, plant-based, or other alternative protein pet foods, cultivated meat will eventually compete for the same customer and the same shelf space. The 2027 timeline gives you two years to watch your current alternative protein velocity before that decision arrives.
If you have passed on alternative proteins entirely, nothing here changes that calculus yet. Cultivated meat at commercial scale is still unproven, and Meatly's move to a pilot facility is a step toward proving it, not proof.
One thing worth tracking: does your premium protein customer, the one buying freeze-dried, raw, or human-grade, ask about lab-grown options when they come in? If that starts appearing in the next 18 months, cultivated meat has consumer pull before it has supply. If it does not, the category arrives as a supplier pitch rather than a customer request, and those play very differently on margin.
Get the next issue in your inbox. Free, weekly, no fluff.